Zobrazeno 1 - 10
of 14
pro vyhledávání: '"S A, Schey"'
Autor:
Mike Y Zhong, Fenghuang Zhan, William Senapedis, S. A. Schey, Andrew L. Kung, Paul G. Richardson, Yolanda Calle, Chirag Acharya, Michaela R. Reagan, Nikhil C. Munshi, Irene M. Ghobrial, Trinayan Kashyap, Michele Cea, Sharon Shacham, Kenneth C. Anderson, M. Kauffman, Daniel Tannenbaum, Lizi Wu, Jean-Richard Saint-Martin, Antonia Cagnetta, Aditya Munshi, Yumei Gu, Yosef Landesman, Yu-Tzu Tai
The key nuclear export protein CRM1/XPO1 may represent a promising novel therapeutic target in human multiple myeloma (MM). Here we showed that chromosome region maintenance 1 (CRM1) is highly expressed in patients with MM, plasma cell leukemia cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c0cfd0f2cee582e49074d8075af2064
http://hdl.handle.net/11567/822469
http://hdl.handle.net/11567/822469
Autor:
S. A. Schey, A. T. Williams
Publikováno v:
International Journal of Food Sciences and Nutrition. 44:17-20
We have investigated, in a group of regular blood donors, the effect of donating a unit of blood on blood haemoglobin concentration, serum iron and ferritin over a three week study period. The fall in haemoglobin was not significant but the fall in s
Publikováno v:
British journal of haematology. 127(3)
Epidemiology data on multiple myeloma (MM) occurrence and outcome is inconsistent whilst a major limitation of randomized controlled trials is selection bias. We present a population-based analysis of patients diagnosed with MM in the South Thames ar
Publikováno v:
Clinical and laboratory haematology. 23(2)
High dose chemoradiotherapy with autologous peripheral blood progenitor cell transplantation (PBPCT) may improve outcome in myeloma. Melphalan is an effective drug in the treatment of myeloma, but is potentially toxic to progenitor cells. We studied
Autor:
S. A., Schey
Publikováno v:
Hematology (Amsterdam, Netherlands). 5(4)
The failure of conventional chemotherapy to eradicate chronic lymphocytic leukaemia cells and induce cure has led many clinicians to investigate the use of high dose chemotherapy and haemopoietic stem cell rescue in this disease. The selection of pat
Autor:
D J, Ramsey, S A, Schey
Publikováno v:
British journal of haematology. 110(4)
Bone marrow or stem cell transplantation is an established therapy for haematological malignancies. We report a cytomegalovirus (CMV) IgG +ve 56-year-old patient who underwent autologous rescue with CD34(+) selected peripheral blood stem cells as par
Publikováno v:
British journal of haematology. 105(4)
Fluconazole is widely used as antifungal prophylaxis but it is ineffective against Aspergillus. Itraconazole has a broader spectrum of activity but the capsules give erratic bioavailability in neutropenic patients. We compared itraconazole oral solut
Publikováno v:
Journal of the Royal College of Physicians of London. 31(3)
Tests for folate and vitamin B12 deficiency are frequently requested by clinicians in many different specialties. An audit of folate assay methodology was undertaken to establish the number of tests and types of assay performed in different centres,
Autor:
S. A. Schey
Publikováno v:
European Journal of Haematology. 42:107-107
Publikováno v:
British journal of haematology. 77(2)
Summary The metabolism and antagonism of vitamin K has been studied in cultured fibroblasts. Monolayers of 3T3 mouse fibroblasts (grown in the absence or presence of warfarin or other putative antagonists) were incubated for 24 h with [1′, 2′-3H2